Strikingly, the authors found that amplification of MAGE-F1, a component of the E3 ubiquitin ligase complex that regulates MMS19 degradation, was associated with significant increases in total mutation burden in lung and head and neck squamous cell carcinomas. This evidence concerns the gene MAGEF1 and head and neck squamous cell carcinoma.